Industry News
Research, Science & Manufacturer Updates
Updates on CRA, Merk & Co., Pfizer, Amgen Inc., Incyte Corp., and more.
The U.S. Department ofHealth and Human Services announced $55.5 million in grants to support training for health professionals and bolster the size of the nation’s healthcare workforce.
Updates on clinical trials for vaccines against a protein believed to cause Alzheimer's, clostridium difficile and RSV.
Researchers at King’s College London have identified a new gene, PIM1, which could be an effective target for innovative treatments and therapies for psoriasis, an autoimmune disease.
A new study conducted by the Centers for Disease Control and Prevention shows that the number of childhood vaccines administered, either in a single day or during the first two years of life, has no bearing on autism risk.
A Canadian study showed that pregnant women who are vaccinated against the flu are significantly less likely to deliver premature or low-birth-weight babies compared with unvaccinated expectant mothers.
DiaVacs’ type 1 diabetes therapy DV-0100 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA).
A new international study has found that vaccines may prevent the risk of strokes in children.
Insurers that want to sell plans through the federal exchanges for 2015 would have to do more to ensure members have access to an adequate network of providers.
The U.S.Department of Health and Human Services (HHS) ruled in February that laboratories are allowed to give patients or their designated representative a means of direct access to the patients’ completed test reports upon their request.
A new study has found that patients who skip an antibiotic often used by hospitals to combat infection during patients’ stays and prescribed to continue that fight after discharge are more likely to return to the hospital.
Low-dose intravenous immune globulin added to a course of corticosteroids has been found to be superior to corticosteroid therapy alone in resolving toxic epidermal necrolysis and reducing associated mortality risk.